Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Lobaplatin/paclitaxel/sintilimab

Lack of efficacy and acute retinal necrosis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wang P, et al. Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fimmu.2024.1301329 Wang P, et al. Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review. [Review] Frontiers in Immunology 15: Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​3389/​fimmu.​2024.​1301329
Metadaten
Titel
Lobaplatin/paclitaxel/sintilimab
Lack of efficacy and acute retinal necrosis
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58271-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Tamoxifen

Case report

Antibacterials

Case report

Multiple drugs